Syra Health (SYRA) CEO Gregory Receives RSU & Option Awards

What Happened

• Alexander Gregory, CEO of Syra Health Corp (SYRA), received two equity awards reported for the January 5, 2026 grant date: 110,537 restricted stock units (RSUs) and 257,920 derivative awards (options or option-like awards). Both awards were reported at a $0.00 acquisition price (typical for compensation grants) and thus show $0 in cash paid. These were reported in an amended Form 4 filed on September 28, 2026.

Key Details

• Transaction date: January 5, 2026; Amended Form 4 filed: September 28, 2026.
• Awards: 110,537 RSUs (reported at $0.00) and 257,920 derivative awards/options (reported at $0.00).
• Vesting: RSUs vest 20% on each of Dec 31, 2026, 2027, 2028, 2029, and 2030 (Footnote F1). Options vest 20% on each of Dec 31, 2026–2030 (Footnote F2).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing status: This is an amended filing submitted well after the grant date; amended or late filings correct prior reports and should be noted by investors but do not by themselves indicate trading intent.

Context

• These entries are awards (compensation), not purchases or exercises — no cash was paid and no shares were sold. Awards are commonly used to align executive incentives with long-term performance; vesting is spread over several years, so the CEO will only realize equity if he remains employed and vesting conditions are met.
• Because this is a grant rather than an open-market purchase, it should be read as a compensation action rather than a direct bullish or bearish trading signal.